Therapeutic action of digitalis glycosides: result of a signal transmitted by a membrane receptor
Luciani, S.
La Clinica Terapeutica 109(2): 101-108
1984
ISSN/ISBN: 0009-9074 PMID: 6329590 Document Number: 223710
Document emailed within 1 workday
Related Documents
Lüllmann, H.; Peters, T.; Preuner, J. 1982: Mechanism of action of digitalis glycosides in the light of new experimental observations European Heart Journal 3 Suppl D: 45-51Mathis, I.; Parigi, A. 1976: Intentional acute poisoning with digitalis glycosides : therapeutic considerations La Clinica Terapeutica 77(2): 183-192
Domzal, K.; Domzal, J. 1975: Determination of concentration of digitalis glycosides in the body performed for therapeutic reasons Postepy Higieny i Medycyny Doswiadczalnej 29(4): 483-499
Lumholtz, I.B. 1980: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 14. Digitalis glycosides Sygeplejersken 80(50): 13
Godfraind, T. 1973: The therapeutic mode of action of cardiac glycosides Archives Internationales de Pharmacodynamie et de Therapie 206(2): 384-388
Burrus, O. 1987: Digitalis glycosides Revue de l'Infirmiere 37(7): 35-38
Bresnahan, J.F.; Vlietstra, R.E. 1979: Digitalis glycosides Mayo Clinic Proceedings 54(10): 675-684
Aono, T.; Yokoyama, Y. 1993: Action mechanism of pituitary hormones--receptor and signal transduction--prolactin Nihon Rinsho. Japanese Journal of Clinical Medicine 51(10): 2631-2635
Huffman, D.H. 1976: Clinical use of digitalis glycosides American Journal of Hospital Pharmacy 33(2): 179-185
Selvaraj, P.; Carpén, O.; Hibbs, M.L.; Springer, T.A. 1989: Natural killer cell and granulocyte Fc gamma receptor IIi (CD16) differ in membrane anchor and signal transduction Journal of Immunology 143(10): 3283-3288
Lehmann, H.U. 1980: Current risks in the use of digitalis glycosides Fortschritte der Medizin 98(5): 172-176
De Micheli, A. 1998: Do digitalis glycosides still serve a purpose? Archivos del Instituto de Cardiologia de Mexico 68(3): 256-261
Genazzani, E. 1977: Pharmacokinetics of the most commonly used digitalis glycosides Minerva Cardioangiologica 25(11): 861-874
De Mey, C.; Snoeck, J. 1980: Review of the use of digitalis glycosides in ventricular dysrhythmia Acta cardiologica 35(2): 153-165
Romanov, M.M.; Abbakumov, S.A. 1973: Development of gynecomastia during treatment with digitalis glycosides Sovetskaia Meditsina 36(3): 142-143
Grosse-Brockhoff, F. 1981: Therapy of cardiac insufficiency with digitalis glycosides Fortschritte der Medizin 99(18): 665-668
Ecker-Schlipf, B. 2008: Digitalis glycosides. what adverse effects can be avoided? Medizinische Monatsschrift für Pharmazeuten 31(4): 157
Globa, A.G.; Zaĭtseva, N.V.; Tepliakov, V.G.; Karelin, A.A. 1992: Formation of cell membrane signal ATP by activated neutrophils and macrophages: connection with superoxide production and formyl peptide receptor status Voprosy Meditsinskoi Khimii 38(3): 13-18
Sandhage, K. 1971: Treatment of cardiac failure using digitalis glycosides in childhood Zeitschrift für Allgemeinmedizin 47(24): 1220-1226
Mikhaĭlov, I.B. 1990: Endogenous digitalis-like substances and cardiac glycosides: facts and hypotheses Farmakologiia i Toksikologiia 53(5): 75-78